Sam Rothstein

Sam Rothstein brings more than 12 years of experience in the design of complex drug products and has led $4 million of Small Business Innovation Research projects on their development. Prior to founding Duo Oncology, Dr. Rothstein began working at the interface of cancer immunotherapy and drug delivery as the CEO of Qrono Inc in 2017. Since joining industry in 2012, Dr. Rothstein has brought three complex drug products into IND-enabling studies. Dr. Rothstein holds chemical engineering degrees from Bucknell University and the University of Pittsburgh.